Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorOui Therapeutics, Inc.
About this trial
The primary objective of this study is to test the feasibility of a digital therapeutic to address comorbid binge eating and obesity in adults.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
English speaking male or female patients, 18-70 years
Patients with recurrent binge eating (≥12 episodes in 3 months) and obesity (BMI ≥30)
Understand written and spoken English
Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
Disqualifiers
Patients with active psychosis
Patients who are acutely intoxicated at the time of enrollment
Currently enrolled in other treatment studies for the symptoms and behaviors targeted
Patients who are cognitively impaired
Trial design
Design model
Single group
Treatments tested in this trial
OTX-401
DeviceEvidence-based treatments for obesity and binge eating
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: TreatmentExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
System Usability Sale (SUS)
The SUS and a semi-structured user feedback interview will be utilized to systematically capture usability and acceptability.
Time frame
Week 12Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Oui Therapeutics, Inc.
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: